Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-10 4:50 pm Purchase | 13D | Landos Biopharma Inc. LABP | Xontogeny LLC | 309,092 9.900% | 309,092 (New Position) | View |
| 2023-03-30 5:27 pm Unchanged | 13D | Landos Biopharma Inc. LABP | Xontogeny LLC | 3,090,924 9.900% | 0 (Unchanged) | View |
| 2022-08-09 09:19 am Purchase | 13D | Landos Biopharma Inc. LABP | Xontogeny LLC | 3,090,924 7.700% | 3,090,924 (New Position) | View |
| 2021-06-25 5:01 pm Purchase | 13D | ASTRIA THERAPEUTICS INC ATXS | Xontogeny LLC | 7,687,185 9.900% | 7,687,185 (New Position) | View |